BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19300157)

  • 21. Outcomes of orbital implants after evisceration and enucleation in patients with endophthalmitis.
    Hui JI
    Curr Opin Ophthalmol; 2010 Sep; 21(5):375-9. PubMed ID: 20489621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of autogenous sclera as wrapping material in hydroxyapatite implantation.
    Yoon JS; Lew H; Kook KH; Lee SY
    Ophthalmologica; 2009; 223(1):7-11. PubMed ID: 18849630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scleral wrap increases the long-term complication risk of bone-derived hydroxyapatite orbital implants.
    Toh T; Bevin TH; Molteno AC
    Clin Exp Ophthalmol; 2008 Nov; 36(8):756-61. PubMed ID: 19128381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mersilene mesh versus sclera in wrapping hydroxyapatite orbital implants.
    Kassaee A; Kashkouli MB; Panjtanpanah M; Sadeghi A; Tabatabaee Z
    Ophthalmic Plast Reconstr Surg; 2006; 22(1):41-4. PubMed ID: 16418664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic hydroxyapatite-based integrated orbital implants: a human pilot trial.
    Kundu B; Sinha MK; Mitra S; Basu D
    Indian J Ophthalmol; 2005 Dec; 53(4):235-41. PubMed ID: 16333171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology.
    Custer PL; Kennedy RH; Woog JJ; Kaltreider SA; Meyer DR
    Ophthalmology; 2003 Oct; 110(10):2054-61. PubMed ID: 14522788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term Surgical Outcomes of the Multi-purpose Conical Porous Synthetic Orbital Implant.
    Kang MJ; Jung SK; Cho WK; Paik JS; Yang SW
    Korean J Ophthalmol; 2015 Oct; 29(5):294-300. PubMed ID: 26457034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term complications of different porous orbital implants: a 21-year review.
    Lin CW; Liao SL
    Br J Ophthalmol; 2017 May; 101(5):681-685. PubMed ID: 27474155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orbital implants in retinoblastoma patients: 23 years of experience and a review of the literature.
    Mourits DL; Moll AC; Bosscha MI; Tan HS; Hartong DT
    Acta Ophthalmol; 2016 Mar; 94(2):165-74. PubMed ID: 26603132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new technique with the hydroxyapatite implant.
    Suvağ N; Katircioğlu Y; Duman S
    Jpn J Ophthalmol; 2004; 48(2):179-80. PubMed ID: 15060803
    [No Abstract]   [Full Text] [Related]  

  • 31. Primary placement of a titanium sleeve in hydroxyapatite orbital implants.
    Liao SL; Chen MS; Lin LL
    Eye (Lond); 2005 Apr; 19(4):400-5. PubMed ID: 15297860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porous Versus Nonporous Orbital Implants After Enucleation for Uveal Melanoma: A Randomized Study.
    Ho VWM; Hussain RN; Czanner G; Sen J; Heimann H; Damato BE
    Ophthalmic Plast Reconstr Surg; 2017; 33(6):452-458. PubMed ID: 27861329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enucleation with reverse replacement of sclera as an alternative to conventional evisceration.
    Madill S; Maclean H
    Orbit; 2005 Mar; 24(1):23-8. PubMed ID: 15764112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Porous orbital implants, wraps, and PEG placement in the pediatric population after enucleation.
    Wang JK; Liao SL; Lin LL; Kao SC; Tseng HS
    Am J Ophthalmol; 2007 Jul; 144(1):109-116. PubMed ID: 17499206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxyapatite orbital implant in children following enucleation: analysis of 531 sockets.
    Shah SU; Shields CL; Lally SE; Shields JA
    Ophthalmic Plast Reconstr Surg; 2015; 31(2):108-14. PubMed ID: 24896774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of orbital prosthesis motility following enucleation or evisceration with sclerotomy with or without a motility coupling post in dogs.
    Yi NY; Park SA; Jeong MB; Kim WT; Kim SE; Kim JY; Chae JM; Jang KJ; Seong JK; Seo KM
    Vet Ophthalmol; 2009; 12(3):139-51. PubMed ID: 19392873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ["On the table evisceration": Technical note].
    Guigue Benayoun H; Foletti JM; Guyot L
    Rev Stomatol Chir Maxillofac Chir Orale; 2016 Feb; 117(1):36-41. PubMed ID: 26776742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical preferences in the management of recalcitrant endophthalmitis.
    Fu R; Childs J; Nunery W; Timoney P
    Orbit; 2018 Oct; 37(5):315-320. PubMed ID: 29300514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late exposure of the bioceramic orbital implant.
    Wang JK; Lai PC; Liao SL
    Am J Ophthalmol; 2009 Jan; 147(1):162-170.e1. PubMed ID: 18571617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evisceration with primary implant placement in patients with endophthalmitis.
    Tawfik HA; Budin H
    Ophthalmology; 2007 Jun; 114(6):1100-3. PubMed ID: 17258811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.